Authors: Mead, GM Bleehen, NM Gregor, A Bullimore, J Murrell, DS Rampling, RP Roberts, JT Glaser, MG Lantos, P Ironside, JW Moss, TH Brada, M Whaley, JB Stenning, SP

Citation: Gm. Mead et al., A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma - Cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy, CANCER, 89(6), 2000, pp. 1359-1370

Authors: Horwich, A Oliver, RTD Wilkinson, PM Mead, GM Harland, SJ Cullen, MH Roberts, JT Fossa, SD Dearnaley, DP Lallemand, E Stenning, SP

Citation: A. Horwich et al., A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma, BR J CANC, 83(12), 2000, pp. 1623-1629

Authors: Collette, L Sylvester, RJ Stenning, SP Fossa, SD Mead, GM de Wit, R de Mulder, PHM Neymark, N Lallemand, E Kaye, SB

Citation: L. Collette et al., Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma, J NAT CANC, 91(10), 1999, pp. 839-846

Authors: Fossa, SD Horwich, A Russell, JM Roberts, JT Cullen, MH Hodson, NJ Jones, WG Yosef, H Duchesne, GM Owen, JR Grosch, EJ Chetiyawardana, AD Reed, NS Widmer, B Stenning, SP

Citation: Sd. Fossa et al., Optimal planning target volume for stage I testicular seminoma: A medical research council randomized trial, J CL ONCOL, 17(4), 1999, pp. 1146-1154

Authors: Fossa, SD Stenning, SP Gerl, A Horwich, A Clark, PI Wilkinson, PM Jones, WG Williams, MV Oliver, RT Newlands, ES Mead, GM Cullen, MH Kaye, SB Rustin, GJS Cook, PA

Citation: Sd. Fossa et al., Prognostic factors in patients progressing after cisplatin based chemotherapy for malignant non-seminomatous germ cell tumours, BR J CANC, 80(9), 1999, pp. 1392-1399